Category: HPB & Spleen

Cystic Plate Approach Enhances Safety in Laparoscopic Hepatectomy

Integrating the cystic plate approach with ICG fluorescence significantly enhances laparoscopic anatomical hepatectomy. In a study of 38 patients, this technique demonstrated no increase in operation time or intraoperative blood loss compared to conventional methods. Postoperative liver function and recovery metrics were also unaffected, confirming the approach’s safety. By utilizing real-time fluoroscopic guidance, the cystic […]

Enhanced recovery after surgery improves outcomes in pancreatoduodenectomy

A systematic review of 22 studies involving 4,043 patients revealed that enhanced recovery after surgery (ERAS) significantly reduced overall complications (relative risk: 0.83) and specifically Clavien-Dindo grade 1 and 2 complications. ERAS also led to a shorter time to chemotherapy. Importantly, ERAS demonstrated no increase in severe complications or mortality risk, thus proving to enhance […]

IAP 2023 Guidelines Enhance Malignancy Prediction for IPMN

The revised IAP 2023 guidelines significantly improved diagnostic performance for predicting malignancy in patients with branch-duct or mixed-type intraductal papillary mucinous neoplasms (IPMN). Among 556 reviewed patients, the guidelines displayed higher specificity (29.1% vs. 4.9% for IAP 2017), a positive predictive value of 48.6%, and greater accuracy (55.5% vs. 44.1%). These improvements could lead to […]

Anatomic resection improves survival for intrahepatic cholangiocarcinoma patients

A systematic review and meta-analysis involving 930 patients revealed that anatomic resection (AR) significantly enhances both overall survival (OS) and disease-free survival (DFS) compared to non-anatomic resection (non-AR) for resectable intrahepatic cholangiocarcinoma. The OS rates at 1, 3, and 5 years were 71.5%, 46.1%, and 34.3% for AR versus 63.6%, 32.9%, and 24.8% for non-AR. […]

ADV score effectively identifies high-risk hepatocellular carcinoma patients

A multicenter study evaluated the ADV score’s efficacy in identifying hepatocellular carcinoma (HCC) patients at high risk of recurrence. The analysis involved 755 patients and established risk groups based on microvascular invasion and Edmonson-Steiner grade. Results showed that the ADV score differentiates these groups effectively, with a 70.2% sensitivity in the training cohort and 78.8% […]

Nomogram predicts survival in pancreatic head cancer patients

A novel nomogram utilizing the number of positive lymph nodes has demonstrated effectiveness in predicting overall survival (OS) for patients with pancreatic head cancer following radical surgery. Analyzed data from over 3,200 patients identified key independent risk factors, including age, tumor extent, and chemotherapy. The nomogram achieved a c-index of 0.652 in the development set […]

HAIP therapy demonstrates comparable survival outcomes for liver tumors

A single-center experience with hepatic artery infusion pump therapy for unresectable colorectal liver metastases showed successful placement in most patients, with a complication rate of 37.5%. The median overall survival (OS) from diagnosis was 55.2 months, though concurrent primary tumor resection led to inferior OS outcomes. Furthermore, the median duration of HAIP therapy was 9.2 […]

PTCD proves more effective than ENBD for treating HCCA

A systematic review and meta-analysis compared endoscopic nasobiliary drainage (ENBD) and percutaneous transhepatic cholangial drainage (PTCD) in advanced hilar cholangiocarcinoma patients. Results indicated PTCD had a significantly higher success rate and was more effective in lowering total bilirubin levels post-drainage. While ENBD showed a lower overall complication rate, it was associated with a higher risk […]

Preoperative systemic therapy improves outcomes for pancreatic cancer patients

A shift towards neoadjuvant therapy in resectable pancreatic adenocarcinoma may enhance surgical success rates. This approach addresses micro-metastatic disease present in many patients, highlighting the necessity of systemic therapy irrespective of resectability. It further allows for tailored treatment selections based on individual tumor biology. Evidence supporting the adoption of neoadjuvant treatment is growing, indicating better […]